• Busca personas
• Intranet

Carcinogénesis gástroesofágica Manuel Pera

Publicaciones 2024 (17)

• Guillot-Morales M^*, Visa L, Brozos-Vázquez E, Feliu-Batlle J, Khosravi P, Laquente-Sáez B, Lopez de San Vicente V, Macarulla T, Gironés-Sarrió R. Update on the management of older patients with pancreatic adenocarcinoma: a perspective from medical oncology. Clin Transl Oncol 2024: (en Premsa).
• Henckens SP, Schuring N, Elliott JA, Johar A, Markar SR, Gantxegi A, Lagergren P, Hanna GB, Pera MR, Reynolds JV, van Berge-Henegouwen MI, Gisbertz SS^*, ENSURE study group. Recurrence and Survival after Minimally Invasive and Open Esophagectomy for Esophageal Cancer - A Post Hoc Analysis of the Ensure Study. Ann Surg 2024: (en Premsa).
• Visser MR, Voeten DM, Gisbertz SS, Ruurda JP, Achiam MP, Nilsson M, Markar SR, Pera MR, Rosati R, Piessen G, Nafteux P, Gutschow CA, Grimminger PP, Räsänen JV, Reynolds JV, Johannessen HO, Vieira P, Weitzendorfer M, Kechagias A, van Berge MI, van Hillegersberg R^*. Western European Variation in the Organization of Esophageal Cancer Surgical Care. Dis Esophagus 2024: (en Premsa).
• de Miguel-Palacio M^*, Gonzalez-Castillo AM, Martín-Ramos M, Membrilla-Fernandez E, Pelegrina A, Pons-Fragero MJ, Grande L, Sancho JJ. Microbiological etiology and current resistance patterns in acute calculous cholecystitis. Cir Espan 2024: (en Premsa).
• Schneider MA, Kim J, Berlth F, Sugita Y, Grimminger PP, Wijnhoven BPL, Overtoom H, Gockel I, Thieme R, Griffiths EA, Butterworth W, Nienhüser H, Müller B, Crnovrsanin N, Gero D, Nickel F, Gisbertz S, van Berge MI, Pucher PH, Khan K, Chaudry A, Patel PH, Pera MR, Dal Cero M, Garcia C, Martinez-Salinas G, Kassab P, Prado-Castro OA, Norero E, Wisniowski P, Putnam LR, Lombardi PM, Ferrari G, Gudaityte R, Maleckas A, Prodehl L, Castaldi A, Prudhomme M, Lee HJ, Sano T, Baiocchi GL, De Manzoni G, Giacopuzzi S, Bencivenga M, Rosati R, Puccetti F, D'Ugo D, Nunobe S, Yang HK, Gutschow CA^*, GASTRODATA consortium. Reconstruction Techniques and Associated Morbidity in Minimally Invasive Gastrectomy for Cancer - Insights from the GastroBenchmark and GASTRODATA databases. Ann Surg 2024: (en Premsa).
• Guerrero MA, Sánchez-Velázquez P, Burdío F, Gimeno M, Podda M, Pellino G, Toledano M, Nuñez J, Bellido J, Acosta-Mérida MA, Vicente E, López-Ben S, Pacheco D, Pando E, Jorba R, Trujillo JPA, Ausania F, Alvarez M, Fernandes N, Castro-Boix S, Gantxegu A, Kraft M, Pinto-Fuentes P, Bueno-Cañones A, Valdes-Hernandez J, Tresierra L, Caruso R, Ferri V, Tio B, Babiloni-Simon S, Lacasa-Martin D, González-Abós C, Guevara-Martinez J, Gutierrez-Iscar E, Sanchez-Santos R, Cano-Valderrama Ó, Nogueira-Sixto M, Alvarez-Garrido N, Martinez-Cortijo S, Lasaia MA, Linacero S, Morante AP, Rotellar F, Arredondo J, Marti P, Sabatella L, Zozaya G, Ielpo B^*. Cost-effectiveness of robotic vs laparoscopic distal pancreatectomy. Results from the national prospective trial ROBOCOSTES. Surg Endosc 2024: (en Premsa).
• Dal Cero M, Gibert J, Grande L, Gimeno M, Osorio J, Bencivenga M, Fumagalli Romario U, Rosati R, Morgagni P, Gisbertz S, Polkowski WP, Lara Santos L, Kolodziejczyk P, Kielan W, Reddavid R, Van Sandick J, Baiocchi GL, Gockel I, Davies A, Wijnhoven BPL, Reim D, Costa P, Allum WH, Piessen G, Reynolds JV, Mönig SP, Schneider PM, Garsot E, Eizaguirre E, Miró M, Castro S, Miranda C, Monzonis X, Pera MR^*, On Behalf Of The Spanish Eurecca Esophagogastric Cancer Group And The European Gastrodata Study Group. International External Validation of Risk Prediction Model of 90-Day Mortality after Gastrectomy for Cancer Using Machine Learning. Cancers 2024; 16(13): 2463.
• Griffiths EA^*, Collaborators (...,Pera MR,...). Predictors of anastomotic leak and conduit necrosis after oesophagectomy: Results from the oesophago-gastric anastomosis audit (OGAA). Eur J Surg Oncol 2024; 50(6): 107983.
• Puértolas-Rico N. Impacto de un programa de ahorro transfusional en pacientes intervenidos de adenocarcinoma gástrico con intención curativa. Universitat Autònoma de Barcelona. Director: Osorio-Aguilar J, Pera MR. Fecha lectura: 21/06/2024.
  Cites:0
• Kroese TE, Bronzwaer S^*, van Rossum PSN, Schoppman SF, Deseyne PRAJ, Van Cutsem E, Haustermans K, Nafteux P, Thomas M, Obermannova R, Mortensen HR, Nordsmark M, Pfeiffer P, Elme A, Adenis A, Piessen G, Bruns CJ, Lordick F, Gockel I, Moehler M, Gani C, Liakakos T, Reynolds JV, Morganti AG, Rosati R, Castoro C, Cellini F, D'Ugo D, Roviello F, Bencivenga M, De Manzoni G, van Berge MI, Hulshoff MCCM, van Dieren J, Vollebergh M, Van Sandick J, Jeene P, Muijs C, Slingerland M, Voncken FEM, Hartgrink H, Creemers GJ, van der Sangen MJC, Nieuwenhuijzen GAP, Berbee M, Verheij M, Wijnhoven B, Beerepoot LV, Mohammad NH, Mook S, Ruurda JP, Kolodziejczyk P, Polkowski WP, Wyrwicz L, Alsina M, Tabernero J, Pera MR, Kanonnikoff TF, Cervantes A, Nilsson M, Monig S, Wagner AD, Guckenberger M, Griffiths EA, Smyth E, Hanna GB, Markar S, Chaudry MA, Hawkins MA, Cheong E, van Laarhoven HWM, van Hillegersberg R^*, OMEC collaborators. European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4). Eur J Cancer 2024; 204: 114062.
• Benaiges D^*, Goday A, Casajoana Badia A, Flores JA, Fitó Colomer M, Pozo O, Serra C, Pera MR, Llauradó G, Climent E, Villatoro M, Lázaro López I, Castañer O, Pedro-Botet J. Short-term effects of gastric bypass versus sleeve gastrectomy on high LDL cholesterol: The BASALTO randomized clinical trial. Cardiovasc Diabetol 2024; 23(1): 205.
• Malpeli G, Filippini F^*, Tedone F, Torroni L, Alloggio M, Castelli C, Dal Cero M, Perris R, Tomezzoli A, De Manzoni G, Bencivenga M. Influence of Tumor Stroma on the Aggressiveness of Poorly Cohesive Gastric Carcinoma. J Pers Med . 2024; 14(2): 194.
• Cuesta JC, Ielpo B, Iglesias M, Burdío F, Sánchez-Velázquez P^*. The impact of vascular margin invasion on local recurrence after pancreatoduodenectomy in pancreatic adenocarcinoma. Langenbecks Arch Surg . 2024; 409(1): 122.
• Grande L^*, Gimeno M, Jimeno J, Pera MR, Sancho JJ, Pera M. Continuous monitoring of adverse effects improves surgical outcomes. Cir Espan 2024; 102(4): 209-215.
• Solé L, Lobo T, Cabré J, Gonzalez A, Fernández-Ibarrondo L, Marruecos L, Guix M, Cuatrecasas M, Lopez S, Bellosillo B, Torres F, Iglesias M, Bigas A, Espinosa L^*. Loss of the epithelial marker CDX1 predicts poor prognosis in early-stage CRC patients. BBA-Mol Cell Res 2024; 1871(3): 119658.
• Masuda Y, Yeo MHX, Burdío F, Sánchez-Velázquez P, Pérez Xaus M, Pelegrina A, Koh YX, Di Martino M, Goh BKP, Tan EK, Teo JY, Romano F, Famularo S, Ferrari C, Griseri G, Piardi T, Sommacale D, Gianotti L, Molfino S, Baiocchi G, Ielpo B^*. Factors affecting overall survival and disease-free survival after surgery for hepatocellular carcinoma: a nomogram-based prognostic model-a Western European multicenter study. Updates Surg 2024; 76(1): 57-69.
• Pérez-Wert P^*, Custodio A, Jiménez Fonseca P, Carmona-Bayonas A, Lecumberri A, Cacho-Lavin D, Losantos-García I, Fernández-Montes A, Cano JM, Limón ML, Hernández-San Gil R, Diez M, Vidal R, Macias I, Visa L, Pimentel-Cáceres P, Gil-Raga M, Martínez-Moreno E, Sauri T, Martin-Richard M, Granja M, Cerdà P, Gomez-Gonzalez L, Mérida-García A, Ruiz-Martín M, Gallego J, AGAMENON-SEOM study group. Efficacy and safety of chemotherapy in young patients with advanced gastroesophageal adenocarcinoma: data from the Spanish AGAMENON-SEOM registry. Gastric Cancer 2024; 27(1): 131-145.